PG Procter & Gamble Co.

$PG | THE PROCTER & GAMBLE COMPANY Q3 2026 EARNINGS HIGHLIGHTS ◆ EPS: $2.00 vs. $1.88 est. ✅ ◆ Revenue: $23.28B vs. $22.80B est. ✅ ◆ Net Income: $4.73B (-0.4% YoY) ◆ Operating Income: $5.94B (+1.4% YoY) ◆ Operating Expenses: $5.66B (+0.3% YoY) ◆ Operating Cash Flow: $5.77B (+6.6% YoY) Segment Performance: ◆ Fabric & Home Care: $8.21B (-3.2% YoY) ◆ Baby, Fem & Family Care: $5.32B (+3% YoY) ◆ Beauty: $4.41B (+6% YoY) ◆ Health Care: $3.32B (+3% YoY) Key Metrics: ◆ Free cash flow was $4.40B in Q1 FY2027, with free cash flow productivity of 93% vs. 102% adjusted in prior year. ◆ Capital expenditures were $1.37B in Q1 FY2027, up from $1.20B in Q1 FY2026, a 13.8% increase. ◆ Share repurchases totaled $1.25B in Q1 FY2027; dividends paid were $2.60B, returning $3.9B total to shareholders. Forward Guidance: ◆ FY2027 all-in sales growth updated to +2% to +4% YoY, reflecting Thorne acquisition as of October 1, 2026. ◆ FY2027 organic sales growth maintained at +1% to +3% YoY; includes 30-50 bps headwind from discontinuations. ◆ FY2027 core EPS growth maintained at 0% to +3% vs. FY2026 core EPS of $6.89; range of $6.89-$7.11, midpoint $7.00. ◆ FY2027 diluted EPS growth maintained at +1% to +5% vs. FY2026 diluted EPS of $6.62.

As investors rotated out of tech, defensive areas such as consumer staples and healthcare saw gains. Procter & Gamble , Walmart and Coca-Cola each rose around 2%, supporting Dow futures. Fellow Dow members Johnson & Johnson and Merck added roughly 2%. “With renewed fears over AI Monetization, the Equity rotation is likely to continue today but the broader indices will reflect Tech’s downside,” JPMorgan traders said in a Friday note. The declines come as investors scrutinize the AI trade. On Thursday, Alphabet shares posted their worst day on record after the company missed on earnings and revenue in the third quarter and posted negative free cash flow of $9.07 billion. The Google-parent’s slide dragged the Nasdaq to a more than 1% loss in the regular session. $PG $WMT $KO $MRK

$PG Don't know what happened to the guy who said he was waiting for $120. I was happy to add to my position in the 140's. When the P/E is in the low 20s and the dividend yield above 3%, it has historically been a great time to accumulate Proctor. Onwards and upwards.

$PG • The Price Action: PG pushed up 1.47% to close at $160.59. • The Validation: This is the beginning of the "coiled spring" release we just broke down. The stock spent the last several days grinding higher from its $158 baseline and is now actively making "higher lows" right underneath the immediate $163.50 macro resistance ceiling. • The Long-Term Takeaway: Big money is quietly anchoring itself here. Watching PG turn green alongside my defense platforms proves that global funds are treating this exact price zone as a premier safety vault.

$PG is ranked #15 in consumer defensive quality with a score of 82. I used Stock Meadow’s scoring model to review the results.

$PG up 15% in 3 weeks? What is this a tech stock? Good earnings and a safe haven stock as the rest of the market pulls back. I own tons of shares but bought next year’s puts as a hedge. Will take put profits (if any) on a retest of 160 and buy more shares.

🚨 TRADE ALERT — $PG 📉 155P | 10/16 EXP 💰 Entry: $0.07 ⚠️ High-risk, low-premium contract. Small size and manage risk carefully. 🎯

$PG is ranked #13 in consumer defensive quality. I used Stock Meadow’s scoring model to review the scores. What do you think?

$PG: P&G tried to move Barton out of California. The court said no on Dec. 11, 2025, keeping the Tampax lead case in San Diego, where a California class was later certified. Lawsuit stage, nothing to claim. Open Class Actions.

$PG What a month so far! The "small" double bottom (green color) playing out perfectly so far, propelled by better than expected earnings last week. Now we need the weekly double bottom (red) to start playing out next, taking us to previous ATH of around 180. The trick is we need to break the 165/167 resistance area as well as the diagonal blue resistance line. Daily currently sitting on the latter. Friday left us with a cliffhanger - after Thursday's pump, profit taking was to be expected (up 15% since the start of the month!). The price can sit there for a while but we need to start seeing some bullish reaction there. If that's the case, the weekly double bottom is at play. If daily does not hold the blue diagonal line, support should be at the neckline of the daily double bottom (152/153).

$PG System Health Check: • SPY Gatekeeper (Weekly RSI 51–85): 58.11 - PASS • SCTR Threshold (≥ 65.0): 81.9 - PASS • Weekly Renko Trend: Active green brick ($159.00) - PASS • Weekly EMA(20): Price above rising EMA ($159.35 > $151.20) - PASS • Weekly RSI(14): 67.48 (Strong momentum) - PASS • 195-Min Setup: Extended (9 green bricks, StochRSI at 1.000) - FAIL • Earnings Date: October 22, 2026 (~4 days away) - FAIL (Earnings Risk) Status: DISQUALIFIED / EARNINGS & EXTENSION CONFLICT Technical Summary: PG demonstrates excellent top-down technical alignment with an 81.9 SCTR, strong weekly Renko trend, and an intact weekly RSI of 67.48. However, the 195-minute chart is fully extended after a 9-green-brick run with StochRSI pinned at 1.000. Furthermore, earnings on October 22 present immediate gap risk, violating the clear calendar runway requirement.

$PG Entering it’s first ever simultaneous consolidation squeeze on the weekly and monthly charts. Entered at around 145. I will be adding all the way up to 200. Playing defensively until she brakes 180. 2028 target is 270.

$PG up 1.2% after an upgrade to "outperform" from "in line" and price-target hike to $166 from $161 at Evercore ISI The firm cited PG's Q1 will likely end downside risk PG is currently working its way further above its year-to-date breakeven mark

https://www.cnbc.com/2026/10/30/jim-cramer-consumer-staples-stocks.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension $PG Procter & Gamble: While the Investing Club exited its longtime P&G position in July, Cramer said the company remains an attractive defensive investment following better-than-expected quarterly results last week. He also expressed confidence in new CEO Shailesh Jejurikar. Shares of Procter & Gamble rallied 11% in October, though Cramer prefers Kimberly-Clark’s lower valuation and higher dividend yield.

$PG: Barton was certified for money and for a possible court order on Tampax labels. The judge also cut back P&G's push to exclude the survey expert. No settlement yet, nothing to claim. Open Class Actions.

$PG: certification is not a safety finding in Barton. The court has not ruled Tampax is unsafe, the FDA has issued no recall, and P&G denies wrongdoing. Lawsuit stage, nothing to claim. Open Class Actions.

$PG The Bullish Chart Setup • The "Cup and Handle" or Flat Base Formation: Over the last several weeks, PG has been building a steady horizontal base around the $161 level. Every time traders try to push the stock down, long-term accumulators step in and aggressively buy the dip, creating a series of "higher lows. “exhibiting the textbook characteristics of a high-probability bullish breakout”.

$PG — Chairman, President & CEO Jejurikar Shailesh sold $5.7M of stock on Oct 23. • 35,000 shares at $163.09. • Sold near the 52-week high. • Stake down 23%.

$PG The Procter & Gamble Company Widely regarded as the ultimate defensive cash machine due to its immense scale and fierce consumer brand loyalty (Tide, Crest, etc.). Possessing an incredibly low beta of 0.41 (making it less than half as volatile as the broader S&P 500), PG recently marked its milestone 70th consecutive annual dividend increase.

$PG weekly very similar pattern to $BRK.X.B from earlier after today's ER breakout move, double bottom break on watch from here over $167.5 close to $173/$180+ in coming days. Support: $161/$156